MX354474B - Composiciones de agente activo resveratrol particuladas, secas y finas y formulaciones topicas que incluyen las mismas. - Google Patents

Composiciones de agente activo resveratrol particuladas, secas y finas y formulaciones topicas que incluyen las mismas.

Info

Publication number
MX354474B
MX354474B MX2015013257A MX2015013257A MX354474B MX 354474 B MX354474 B MX 354474B MX 2015013257 A MX2015013257 A MX 2015013257A MX 2015013257 A MX2015013257 A MX 2015013257A MX 354474 B MX354474 B MX 354474B
Authority
MX
Mexico
Prior art keywords
dry particulate
same
topical formulations
active agent
fine dry
Prior art date
Application number
MX2015013257A
Other languages
English (en)
Other versions
MX2015013257A (es
Inventor
Zahra Mansouri
Original Assignee
Laboratory Skin Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratory Skin Care Inc filed Critical Laboratory Skin Care Inc
Publication of MX2015013257A publication Critical patent/MX2015013257A/es
Publication of MX354474B publication Critical patent/MX354474B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan composiciones de resveratrol particulado seco y fino adecuadas para usarse en formulaciones tópicas, así como los métodos para hacer las mismas; en la composición de resveratrol particulado, el agente activo de resveratrol está asociado con las partículas, es decir, a través de atrapamiento de las partículas en los poros y/o enlace iónico y/o enlace no covalente de las partículas a la superficie y/o holgadamente asociado con las partículas; también se proporcionan formulaciones tópicas que incluyen las composiciones de resveratrol particulado seco de la invención, y métodos para usar las mismas.
MX2015013257A 2013-03-15 2014-03-14 Composiciones de agente activo resveratrol particuladas, secas y finas y formulaciones topicas que incluyen las mismas. MX354474B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361798727P 2013-03-15 2013-03-15
PCT/US2014/029761 WO2014145093A1 (en) 2013-03-15 2014-03-14 Fine dry particulate resveratrol active agent compositions and topical formulations including the same

Publications (2)

Publication Number Publication Date
MX2015013257A MX2015013257A (es) 2016-04-15
MX354474B true MX354474B (es) 2018-03-07

Family

ID=51528083

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013257A MX354474B (es) 2013-03-15 2014-03-14 Composiciones de agente activo resveratrol particuladas, secas y finas y formulaciones topicas que incluyen las mismas.

Country Status (14)

Country Link
US (1) US9192673B2 (es)
EP (1) EP2968156A4 (es)
JP (1) JP2016514696A (es)
KR (1) KR20150129012A (es)
CN (2) CN105188678A (es)
AU (1) AU2014233388A1 (es)
BR (1) BR112015022965A2 (es)
CA (1) CA2906873A1 (es)
CL (1) CL2015002690A1 (es)
EA (1) EA201591827A1 (es)
MX (1) MX354474B (es)
MY (1) MY175420A (es)
SG (1) SG11201507651XA (es)
WO (1) WO2014145093A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055307A (en) * 1988-12-29 1991-10-08 Asahi Kagaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US4948575A (en) 1989-01-24 1990-08-14 Minnesota Mining And Manufacturing Company Alginate hydrogel foam wound dressing
US5158756A (en) 1989-06-24 1992-10-27 Asahi Kogaku Kogyo Kabushiki Kaisha Porous particles of calcium phosphate compound and production process thereof
US5604200A (en) 1994-05-02 1997-02-18 Taylor-Mccord; Darlene Wound therapeutic mixture containing medical grade hyaluronic acid and tissue culture grade plasma-fibronectin in a delivery system that creates a moist environment which simulates in utero healing
US6579516B1 (en) 1995-06-13 2003-06-17 Zahra Mansouri Methods of delivering materials into the skin, and compositions used therein
US6096324A (en) 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US6395311B2 (en) 1998-04-29 2002-05-28 Univera Pharmaceuticals, Inc. Multicomponent biological vehicle
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6262020B1 (en) 2000-02-15 2001-07-17 Alphamed Pharmaceuticals Corp. Topical wound therapeutic compositions
US6573249B2 (en) 2000-02-15 2003-06-03 Alphamed Pharmaceutical Corp. Topical wound therapeutic compositions
CN1106861C (zh) 2000-05-19 2003-04-30 清华大学 纳米相钙磷盐/胶原/聚乳酸骨复合多孔材料的制备方法
JP4161031B2 (ja) 2000-10-31 2008-10-08 独立行政法人産業技術総合研究所 亜鉛含有リン酸カルシウム微粒子含有懸濁液または粒子溶媒混合系及び亜鉛欠乏症治療剤
JP2004075662A (ja) 2002-06-20 2004-03-11 Mukku:Kk 徐放性組成物、その製造方法およびその製剤
WO2004091577A1 (en) 2003-04-17 2004-10-28 Porten Pharmaceutical Ab Composition, method and pharmaceutical preparation for pharmaceutical spray suspensions
EP1676813A4 (en) 2003-08-22 2009-08-12 Nat Inst For Materials Science POROUS US SPHERICAL CALCIUM PHOSPHATES PARTICULARLY SUBSTITUTED WITH A METALION OR WEARING ON ITS SURFACE A METALLION, AND POROUS MULTILAYER CALCIUM PHOSPHATE PARTICLES
WO2005084637A2 (en) 2004-02-13 2005-09-15 Nod Pharmaceuticals, Inc. Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
EP1737378A2 (en) 2004-04-02 2007-01-03 Baylor College of Medicine Novel modification of medical prostheses
SE527610C2 (sv) 2004-06-15 2006-04-25 Promimic Ab Förfarande för framställning av syntetiskt, kristallint kalciumfosfat i nanostorlek
CA2586035A1 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
EP1894565B1 (en) * 2005-06-10 2013-10-30 Pierre Fabre Médicament S.A. Stabilized milnacipran formulation
CN1813657A (zh) 2005-12-15 2006-08-09 孙振淋 纳米磷酸钙类盐在化妆产品中的应用方法
US20080051335A1 (en) 2006-05-02 2008-02-28 Kleiner Lothar W Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers
AU2007333425B2 (en) 2006-11-03 2014-03-27 Biomimetic Therapeutics, Llc Compositions and methods for arthrodetic procedures
US8080583B2 (en) * 2007-07-31 2011-12-20 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone
US20090035240A1 (en) 2007-07-31 2009-02-05 Maes Daniel H Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
US20090035236A1 (en) 2007-07-31 2009-02-05 Maes Daniel H Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent
US8344024B2 (en) * 2007-07-31 2013-01-01 Elc Management Llc Anhydrous cosmetic compositions containing resveratrol derivatives
US20090099651A1 (en) 2007-10-10 2009-04-16 Miv Therapeutics, Inc. Lipid coatings for implantable medical devices
BR112012006635B8 (pt) * 2008-09-23 2021-05-25 Laboratory Skin Care Inc composição que compreende partículas de tamanho micro de fosfato de cálcio uniformes, rígidas, esféricas, nanoporosas e método para combinar e separar o solvente não aquoso das referidas partículas
WO2010102245A1 (en) * 2009-03-05 2010-09-10 Upsher-Smith Laboratories, Inc. Solid dispersion comprising resveratrol
IL255113B (en) * 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
EP2461840A4 (en) 2009-08-04 2013-11-06 Biomatcell Ab IONALLY SUBSTITUTED CALCIUM PHOSPHATE PARTICLES
CN102631686A (zh) * 2012-04-18 2012-08-15 上海师范大学 一种多孔磷酸钙纳米粒子-反义寡聚核苷酸复合物及制备方法和应用

Also Published As

Publication number Publication date
AU2014233388A1 (en) 2015-11-05
CN112675157A (zh) 2021-04-20
SG11201507651XA (en) 2015-10-29
EP2968156A4 (en) 2017-01-11
MY175420A (en) 2020-06-24
WO2014145093A1 (en) 2014-09-18
JP2016514696A (ja) 2016-05-23
EA201591827A1 (ru) 2016-01-29
EP2968156A1 (en) 2016-01-20
CL2015002690A1 (es) 2016-04-08
KR20150129012A (ko) 2015-11-18
CN105188678A (zh) 2015-12-23
US20140271880A1 (en) 2014-09-18
CA2906873A1 (en) 2014-09-18
US9192673B2 (en) 2015-11-24
MX2015013257A (es) 2016-04-15
BR112015022965A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
MX2015013254A (es) Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas.
PH12019500522A1 (en) Tetrahydropyrazolopyrimidine compounds
MX2019005192A (es) Compuestos de quinolina selectivamente sustituida.
GB2535876A (en) Absorbent clumping animal litter compositions
EA201370018A1 (ru) Составы рифаксимина и их применение
EA201590491A1 (ru) Иммуногенная композиция
TN2015000371A1 (en) Substituted imidazopyridazines
EA201790461A1 (ru) Композиции внеклеточного матрикса
WO2014159669A3 (en) Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions
GB2514741A (en) Composition for use as a paint binder
PL2989192T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
FR3002414B1 (fr) Composition rodenticide sous forme de cereales et/ou de graines agglomerees.
PH12015502717A1 (en) Anti-fibrogenic compounds, methods and uses thereof
MY175420A (en) Fine dry particulate resveratrol active agent compositions and topical formulations including the same
EA201492280A1 (ru) Стабильный состав пексиганана
BR112018070603A2 (pt) formulações líquidas de fosfaplatina
LV15003A (lv) Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei
ES2426017A2 (es) Microemulsión que comprende colagenasa y usos
IN2013MU03429A (es)
MX2016001694A (es) Formulacion de vacuna de sacarido.
UA78375U (ru) Применение сорбента "силикс" как антисептического и вяжущего средства

Legal Events

Date Code Title Description
FG Grant or registration